These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 902454)

  • 1. Patterns of plasma concentrations and urinary excretion of salicylate in rheumatoid arthritis.
    Graham GG; Champion GD; Day RO; Paull PD
    Clin Pharmacol Ther; 1977 Oct; 22(4):410-20. PubMed ID: 902454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salicyl phenolic glucuronide pharmacokinetics in patients with rheumatoid arthritis.
    Bochner F; Graham GG; Polverino A; Imhoff DM; Tregenza RA; Rolan PE; Cleland LG
    Eur J Clin Pharmacol; 1987; 32(2):153-8. PubMed ID: 3582479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of and clinical response to salicylates in patients with rheumatoid disease.
    Günsberg M; Bochner F; Graham G; Imhoff D; Parsons G; Cham B
    Clin Pharmacol Ther; 1984 May; 35(5):585-93. PubMed ID: 6713771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of salicylate during chronic aspirin therapy.
    Rumble RH; Brooks PM; Roberts MS
    Br J Clin Pharmacol; 1980 Jan; 9(1):41-5. PubMed ID: 7356892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of plateau serum salicylate level with rate of salicylate metabolism.
    Gupta N; Sarkissian E; Paulus HE
    Clin Pharmacol Ther; 1975 Sep; 18(3):350-5. PubMed ID: 1100304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of age, gender, and obesity on salicylate kinetics following single doses of aspirin.
    Greenblatt DJ; Abernethy DR; Boxenbaum HG; Matlis R; Ochs HR; Harmatz JS; Shader RI
    Arthritis Rheum; 1986 Aug; 29(8):971-80. PubMed ID: 3741521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: Kinetics of salicylate metabolism.
    Gibson T; Zaphiropoulos G; Grove J; Widdop B; Berry D
    Ann Rheum Dis; 1974 Jul; 33(4):410-1. PubMed ID: 4278234
    [No Abstract]   [Full Text] [Related]  

  • 8. Salicylate pharmacokinetics in patients with rheumatoid arthritis.
    Owen SG; Roberts MS; Friesen WT; Francis HW
    Br J Clin Pharmacol; 1989 Oct; 28(4):449-61. PubMed ID: 2590603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in the pharmacokinetics of salicylates.
    Trnavská Z; Trnavský K
    Eur J Clin Pharmacol; 1983; 25(5):679-82. PubMed ID: 6662166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacokinetics of the salicylates.
    Needs CJ; Brooks PM
    Clin Pharmacokinet; 1985; 10(2):164-77. PubMed ID: 3888490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of salicylate metabolism.
    Gibson T; Zaphiropoulos G; Grove J; Widdop B; Berry D
    Br J Clin Pharmacol; 1975 Jun; 2(3):233-8. PubMed ID: 136263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salicylate metabolism: effects of age and sex in adults.
    Montgomery PR; Berger LG; Mitenko PA; Sitar DS
    Clin Pharmacol Ther; 1986 May; 39(5):571-6. PubMed ID: 3698465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of aspirin after therapeutic and toxic doses.
    Patel DK; Hesse A; Ogunbona A; Notarianni LJ; Bennett PN
    Hum Exp Toxicol; 1990 May; 9(3):131-6. PubMed ID: 2375880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacokinetic comparison of choline magnesium trisalicylate and soluble aspirin.
    Helliwell M; Gibson T; Berry D; Volans G
    Br J Rheumatol; 1984 Nov; 23(4):288-91. PubMed ID: 6487934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steady-state salicylate plasma and urinary metabolite concentrations from plain, buffered, or enteric-coated aspirin.
    Allen JH; Thakker KM; Small RE; Wood JH; Willis HE
    Clin Pharm; 1983; 2(1):64-6. PubMed ID: 6883933
    [No Abstract]   [Full Text] [Related]  

  • 16. Urinary excretion of salicyluric and salicylic acids by non-vegetarians, vegetarians, and patients taking low dose aspirin.
    Lawrence JR; Peter R; Baxter GJ; Robson J; Graham AB; Paterson JR
    J Clin Pathol; 2003 Sep; 56(9):651-3. PubMed ID: 12944546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of salicylates: a re-assessment.
    Levy G
    Br J Clin Pharmacol; 1980 Oct; 10 Suppl 2(Suppl 2):285S-290S. PubMed ID: 7437270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salicylate metabolite kinetics after several salicylates.
    Bochner F; Graham GG; Cham BE; Imhoff DM; Haavisto TM
    Clin Pharmacol Ther; 1981 Aug; 30(2):266-75. PubMed ID: 7249509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal acquisition and neonatal elimination of a large amount of salicylate. Study of a neonate whose mother regularly took therapeutic doses of aspirin during pregnancy.
    Garrettson LK; Procknal JA; Levy G
    Clin Pharmacol Ther; 1975 Jan; 17(1):98-103. PubMed ID: 235394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative plasma salicylate and urine salicylurate levels following administration of aspirin, magnesium salicylate, and choline magnesium trisalicylate.
    Mason WD
    J Pharm Sci; 1980 Nov; 69(11):1355-6. PubMed ID: 7452472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.